RxDoctor Payments DataLook up a doctor →

BRILINTA: payments to doctors

Payments that named BRILINTA as the associated drug or biological, reported under the Sunshine Act for program years 20192025.

Total reported
$5.7M
Providers
28,381
Transactions
109,912
Average per transaction
$52

The per-transaction average — $52 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 28,381 providers the average total is $201, but that average hides a very steep distribution.

Companies reporting these payments

CompanyTotal reportedShare
AstraZeneca$5,527,43496.7%
Astrazeneca AB$97,2271.7%
Astrazeneca UK Limited$91,5831.6%
Acerta Pharma LLC$1,2320.0%
← All drugs & devices